← Leaderboards
Rebecca L. O'Brien
National Jewish Health
$6,425,244
Attributed
$6,425,244
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $648.1K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$6,425,244 · 7
By mechanism
R01$4,598,498 · 2
R21$1,278,896 · 3
R56$396,250 · 1
R03$151,600 · 1
Top collaborators
No co-investigators on record.
Most similar at National Jewish Health
Same institution · by research overlap
- James Scott-Browne$2,269,340
- Jennifer L Chain$149,034
- Willi K Born$4,873,117
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineT-LymphocytePlayImmune ResponseCellsAutoimmune ProcessLaboratory MouseImmuneT Cell ReceptorInflammationFlow CytometryListeriaInflammatory ResponseApoptosisCell TypeT-Lymphocyte SubsetsT LymphocyteAdoptive TransferPreventMediatingResponseImmunobiologyLeukocyte Activation /TransformationGenetically Modified Animals
Grant awards (23)
Gamma/delta T cells in autoimmune keratitis$388,325
R01 · FY2015 · EY · contact PI
Gamma/delta T cells in autoimmune keratitis$388,325
R01 · FY2014 · EY · contact PI
Gamma/delta T cells in autoimmune keratitis$376,438
R01 · FY2013 · EY · contact PI
The role of gamma/delta T cells in type 1 diabetes$198,125
R21 · FY2013 · AI · contact PI
Gamma/delta T cells in autoimmune keratitis$396,250
R01 · FY2012 · EY · contact PI
The role of gamma/delta T cells in type 1 diabetes$237,750
R21 · FY2012 · AI · contact PI
Spontaneous Keratitis in T-Cell Deficient Female Mice$187,200
R21 · FY2011 · EY · contact PI
Discovery and Investigation of Gamma/Delta TCR Ligands$396,250
R56 · FY2010 · AI · contact PI
Spontaneous Keratitis in T-Cell Deficient Female Mice$234,000
R21 · FY2010 · EY · contact PI
The Basis of Functional Variation in Gamma/Delta T cells$68,250
R01 · FY2009 · AI · contact PI
The Basis of Functional Variation in Gamma/Delta T cells$352,532
R01 · FY2008 · AI · contact PI
The Basis of Functional Variation in Gamma/Delta T cells$359,360
R01 · FY2007 · AI · contact PI
The Basis of Functional Variation in Gamma/Delta T cells$370,094
R01 · FY2006 · AI · contact PI
Identifying Ligands with Soluble Gamma/Delta TCRs$228,501
R21 · FY2006 · AI · contact PI
The Basis of Functional Variation in Gamma/Delta T cells$379,000
R01 · FY2005 · AI
Identifying Ligands with Soluble Gamma/Delta TCRs$193,320
R21 · FY2005 · AI
Spontaneous Corneal Inflammation in gd T cell absence$75,800
R03 · FY2005 · EY
The Basis of Functional Variation in Gamma/Delta T cells$379,000
R01 · FY2004 · AI
Spontaneous Corneal Inflammation in gd T cell absence$75,800
R03 · FY2004 · EY
MECHANISM OF A FUNCTIONAL SWITCH IN GAMMA DELTA T CELLS$298,000
R01 · FY2003 · AI
MECHANISM OF A FUNCTIONAL SWITCH IN GAMMA DELTA T CELLS$289,319
R01 · FY2002 · AI
MECHANISM OF A FUNCTIONAL SWITCH IN GAMMA DELTA T CELLS$280,893
R01 · FY2001 · AI
MECHANISM OF A FUNCTIONAL SWITCH IN GAMMA DELTA T CELLS$272,712
R01 · FY2000 · AI